Opzelura Cream Dosage
Generic name: RUXOLITINIB PHOSPHATE 15mg in 1g
Dosage form: cream
Drug class: Topical antineoplastics
Medically reviewed by Drugs.com. Last updated on Sep 20, 2023.
Important Administration Instructions
Do not use more than one 60 gram tube per week or one 100 gram tube per 2 weeks.
OPZELURA is for topical use only. OPZELURA is not for ophthalmic, oral, or intravaginal use.
2.2 Recommended Dosage for Atopic Dermatitis
Instruct patients to apply a thin layer of OPZELURA twice daily to affected areas of up to 20% body surface area.
Stop using when signs and symptoms (e.g., itch, rash, and redness) of atopic dermatitis resolve. If signs and symptoms do not improve within 8 weeks, patients should be re-examined by their healthcare provider [see Clinical Studies (14.1)].
Recommended Dosage for Nonsegmental Vitiligo
Instruct patients to apply a thin layer of OPZELURA twice daily to affected areas of up to 10% body surface area.
Satisfactory patient response may require treatment with OPZELURA for more than 24 weeks. If the patient does not find the repigmentation meaningful by 24 weeks, the patient should be re‑evaluated by the healthcare provider [see Clinical Studies (14.2)].
Frequently asked questions
- What are the most common skin conditions? (with photos)
- What are JAK inhibitors and how do they work?
- Which JAK inhibitors are approved in the U.S?
More about Opzelura (ruxolitinib topical)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- FDA approval history
- Drug class: topical antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
